Iacopo Olivotto
Iacopo Olivotto is an expert in Cardiology at Careggi University Hospital (Italy). As of October 2026, ScienceLeadR ranks Iacopo Olivotto in the top 1% of experts worldwide for Cardiomyopathies, Aortic Valve Disease and Cardiomegaly. Iacopo Olivotto has authored 865 publications, the most recent in 2026, and is an investigator in 27 clinical trials, 11 of them ongoing. SLR score: 3,708 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Public Health - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 865
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry. PMID 42417692 — registries, natural history, heart failure, atrial fibrillation, cardiology, signs and symptoms, therapeutics, history | J Am Coll Cardiol | 2026 | 5 |
| Genotype and arrhythmic risk in dilated cardiomyopathy. PMID 42864989 — cardiomyopathy, dilated, genes, arrhythmias, cardiac, cardiology, sex, genotype, diagnosis, cardiomyopathies | Eur Heart J Top journal | 2026 | 1 |
| Noninvasive Characterization of Myocardial Diseases With Hypertrophic Phenotypes Using Integrated ECG/Echocardiographic Indices. PMID 42786594 — heart diseases, phenotype, cardiomyopathy, hypertrophic, echocardiography, cardiomyopathies, fabry disease | J Am Heart Assoc | 2026 | 1 |
| Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry. PMID 42779549 — registries, genes, genetics, amino acids, heart, arrhythmias, cardiac, atrial fibrillation, cardiomyopathy, hypertrophic, odds ratio, diagnosis, transplants, cardiomyopathies | Circ Genom Precis Med | 2026 | 0 |
| Pangenomes aid accurate detection of large insertions and deletions from targeted sequencing: the case of cardiomyopathies. PMID 42723105 — genes, genomics, workflow, genome, work, cardiomyopathies | Genome Med | 2026 | 0 |
Clinical Studies 27
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
11 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The ENERGY 2 Study A study to investigate if study drug INZ 701 increases survival in infants with ENPP1 Deficiency by preventing heart dysfunction and calcification of arteries 2024-512991-36-00 — phosphoric diester hydrolases, safety, pharmaceutical preparations, heart, arteries, pyrophosphatases, therapeutics, infant | Phase 3 | Recruiting | 2024 |
| A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy 2025-522553-19-00 — exercise, cardiomyopathy, dilated, safety, cardiomyopathies | Phase 2/Phase 3 | Recruiting | 2026 |
| A Study of Mavacamten in Adolescent Participants with Symptomatic Obstructive Hypertrophic Cardiomyopathy 2023-505650-17-00 — cardiomyopathy, hypertrophic, adolescent, cardiomyopathies | Phase 3 | Active not recruiting | 2024 |
| A randomized double blinded placebo controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non obstructive hypertrophic cardiomyopathy 2024-515125-28-00 — safety, cardiomyopathy, hypertrophic, therapeutics, cardiomyopathies | Phase 2 | Recruiting | 2025 |
| Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443 — cardiomyopathy, dilated, glycogen, laminopathies, death, sudden, glycogen storage disease, myotonic dystrophy, heart failure, heart, micrornas, magnetic resonance imaging, hypertrophy, cardiomyopathy, hypertrophic, amyloidosis, heart transplantation, death, sudden, cardiac, tissues, transplantation, cardiomyopathies, fabry disease, rna | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map